Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "disorder"

620 News Found

Fortis Bannerghatta launches SWARA Clinic for integrated voice, airway and swallowing care
Hospitals | April 16, 2026

Fortis Bannerghatta launches SWARA Clinic for integrated voice, airway and swallowing care

The new outpatient-focused clinic is designed to address voice, airway and swallowing disorders through advanced diagnostics


Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy
News | April 16, 2026

Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy

Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%


Aurigene, Alveus advance obesity pipeline with ALV-200 candidate nomination
R&D | April 16, 2026

Aurigene, Alveus advance obesity pipeline with ALV-200 candidate nomination

The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities


Marengo Asia launches functional neurosurgery centre, dance therapy for Parkinson’s care
Hospitals | April 16, 2026

Marengo Asia launches functional neurosurgery centre, dance therapy for Parkinson’s care

The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation


Teva launches Home Ground platform to tackle isolation in schizophrenia care
Digitisation | April 16, 2026

Teva launches Home Ground platform to tackle isolation in schizophrenia care

The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping


Dr Jitendra Singh stresses strong clinical foundations in medical education amid AI expansion
Healthcare | April 15, 2026

Dr Jitendra Singh stresses strong clinical foundations in medical education amid AI expansion

At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning


MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price
Drug Approval | April 15, 2026

MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price

CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing


Alexion to showcase broad neurology pipeline at AAN 2026 with 20 presentations
R&D | April 14, 2026

Alexion to showcase broad neurology pipeline at AAN 2026 with 20 presentations

The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies


Kolkata gets advanced liver care hub as Manipal Hospitals targets critical treatment gap
Hospitals | April 14, 2026

Kolkata gets advanced liver care hub as Manipal Hospitals targets critical treatment gap

The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network